Cotinine and Tobacco-Specific Carcinogen Exposure Among Nondaily Smokers in a Multiethnic Sample

被引:21
|
作者
Khariwala, Samir S. [1 ]
Scheuermann, Taneisha S. [2 ]
Berg, Carla J. [3 ]
Hayes, Rashelle B. [4 ]
Nollen, Nicole L. [5 ]
Thomas, Janet L. [2 ]
Guo, Hongfei [6 ]
Ahluwalia, Jasjit S. [2 ]
Benowitz, Neal L. [7 ]
机构
[1] Univ Minnesota, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Univ Massachusetts Med Sch, Dept Prevent & Behav Med, Worcester, MA USA
[5] Univ Kansas Med Ctr, Dept Prevent Med & Publ Hlth, Kansas City, MO USA
[6] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[7] Univ Calif San Francisco, Dept Clin Pharmacol, San Francisco, CA 94143 USA
关键词
LUNG-CANCER DEVELOPMENT; URINARY LEVELS; METABOLITE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL; RACIAL-DIFFERENCES; NICOTINE; SMOKING; INTERMITTENT; RISK;
D O I
10.1093/ntr/ntt194
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Nondaily smoking has increased among current U.S. smokers during the past decade and is practiced by a significant percentage of smokers. Although research in nondaily smoking has grown, little is known about levels of exposure to tobacco toxicants among nondaily smokers and their variation across ethnic groups. We examined urinary levels of cotinine and a tobacco-specific nitrosamine (NNAL) in community participants. Associations between the biomarker data and smoking characteristics were evaluated with Spearmans correlation analysis. Participants included 28 Blacks, 4 Latinos, and 25 Whites who smoked at least 1 cigarette on 424 days in the past 30 days. Participants averaged 3.3 (SD 2.1) cigarettes per day (cpd) on days smoked, they smoked an average of 13.0 (SD 5.4) days in the past month, and they smoked nondaily for 10.5 (SD 10.5) years. Median levels of creatinine-normalized cotinine and NNAL were 490.9ng/mg and 140.7 pg/mg, respectively. NNAL and cotinine were highly correlated (r .84); NNAL and cotinine were modestly correlated with cpd (r .39 and r .34; all p values <.05). The number of days smoked per month was not associated with any biomarker levels. Our findings demonstrate that nondaily smokers are, on average, exposed to significant levels of nicotine and carcinogenic nitrosamines, with exposures of 40%50% of those seen in daily smokers. This level of exposure suggests a significant health risk. Nicotine and carcinogen exposure is most closely related to number of cigarettes smoked per day but not to number of days per month of smoking.
引用
收藏
页码:600 / 605
页数:6
相关论文
共 50 条
  • [21] Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages
    Therriault, MJ
    Proulx, LI
    Castonguay, A
    Bissonnette, ÉY
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (02): : 232 - 238
  • [22] A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers
    Murphy, SE
    Link, CA
    Jensen, J
    Le, C
    Puumala, SS
    Hecht, SS
    Carmella, SG
    Losey, L
    Hatsukami, DK
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (10) : 1617 - 1623
  • [23] Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons
    Anderson, KE
    Kliris, J
    Murphy, L
    Carmella, SG
    Han, SM
    Link, C
    Bliss, RL
    Puumala, S
    Murphy, SE
    Hecht, SS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1544 - 1546
  • [24] Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers
    Yuan, Jian-Min
    Knezevich, Aleksandar D.
    Wang, Renwei
    Gao, Yu-Tang
    Hecht, Stephen S.
    Stepanov, Irina
    CARCINOGENESIS, 2011, 32 (09) : 1366 - 1371
  • [25] Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke
    Anderson, KE
    Carmella, SG
    Ye, M
    Bliss, RL
    Le, C
    Murphy, L
    Hecht, SS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (05) : 378 - 381
  • [26] EXOGENOUS AND ENDOGENOUS EXPOSURE TO TOBACCO-SPECIFIC NITROSAMINES
    TRICKER, AR
    SCHERER, G
    ADLKOFER, F
    PACHINGER, A
    KLUS, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 158 - AGFD
  • [27] Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers
    Yuan, Jian-Min
    Stepanov, Irina
    Murphy, Sharon E.
    Wang, Renwei
    Allen, Sharon
    Jensen, Joni
    Strayer, Lori
    Adams-Haduch, Jennifer
    Upadhyaya, Pramod
    Le, Chap
    Kurzer, Mindy S.
    Nelson, Heather H.
    Yu, Mimi C.
    Hatsukami, Dorothy
    Hecht, Stephen S.
    CANCER PREVENTION RESEARCH, 2016, 9 (05) : 396 - 405
  • [28] HUMAN EXPOSURE TO A TOBACCO-SPECIFIC NITROSAMINO ACID
    TRICKER, AR
    SCHERER, G
    ADLKOFER, F
    PACHINGER, K
    KLUS, H
    NITROSAMINES AND RELATED N-NITROSO COMPOUNDS: CHEMISTRY AND BIOCHEMISTRY, 1994, 553 : 363 - 364
  • [29] Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen
    Hecht, SS
    Murphy, SE
    Carmella, SG
    Zimmerman, CL
    Losey, L
    Kramarczuk, I
    Roe, MR
    Puumala, SS
    Li, YS
    Le, C
    Jensen, J
    Hatsukami, DK
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (02): : 107 - 115
  • [30] Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers
    Tulunay, ZE
    Hecht, SS
    Carmella, SG
    Zhang, Y
    Lernmonds, C
    Murphy, S
    Hatsukami, DK
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1283 - 1286